Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human MUC1-Tn/STn Antibody (5E5#) | Login | Anti-Human MUC1-Tn/STn Antibody (5E5#) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD227/MUC1 Antibody (SAA0075) | Login | Anti-Human CD227/MUC1 Antibody (SAA0075) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD23/FCER2 Antibody (P5E8) | Login | Anti-Human CD23/FCER2 Antibody (P5E8) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD243/P-Glycoprotein Antibody (C219) | Login | Anti-Human CD243/P-Glycoprotein Antibody (C219) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD25/IL2RA Antibody (1H4) | Login | Anti-Human CD25/IL2RA Antibody (1H4) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD25/IL2RA Antibody (ADCT-301) | Login | Anti-Human CD25/IL2RA Antibody (ADCT-301) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD25/IL2RA Antibody (SAA0008) | Login | Anti-Human CD25/IL2RA Antibody (SAA0008) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD254/RANKL/TNFSF11 Antibody (SAA0080) | Login | Anti-Human CD254/RANKL/TNFSF11 Antibody (SAA0080) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD256/TNFSF13 Antibody (VIS-649) | Login | Anti-Human CD256/TNFSF13 Antibody (VIS-649) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA0083) | Login | Anti-Human CD261/TNFRSF10A/DR4 Antibody (SAA0083) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD262/TNFRSF10B/TRAIL-R2 Antibody (SAA0084) | Login | Anti-Human CD262/TNFRSF10B/TRAIL-R2 Antibody (SAA0084) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD262/TNFRSF10B/TRAIL-R2 Antibody (SAA0085) | Login | Anti-Human CD262/TNFRSF10B/TRAIL-R2 Antibody (SAA0085) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD275/ICOSLG Antibody (SAA0089) | Login | Anti-Human CD275/ICOSLG Antibody (SAA0089) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD325/CDH2 Antibody (1H7) | Login | Anti-Human CD325/CDH2 Antibody (1H7) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD326/EPCAM Antibody (17-1A) | Login | Anti-Human CD326/EPCAM Antibody (17-1A) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD326/EPCAM Antibody (MT201) | Login | Anti-Human CD326/EPCAM Antibody (MT201) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD33 Antibody (P67.6) | Login | Anti-Human CD33 Antibody (P67.6) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD33 Antibody (M195) | Login | Anti-Human CD33 Antibody (M195) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD331/FGFR1 Antibody (A08) | Login | Anti-Human CD331/FGFR1 Antibody (A08) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD332/FGFR2 Antibody (Gal-FR21) | Login | Anti-Human CD332/FGFR2 Antibody (Gal-FR21) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD332/FGFR2 Antibody (SAA0099) | Login | Anti-Human CD332/FGFR2 Antibody (SAA0099) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD340/ERBB2/HER2 Antibody (4D5V8) | Login | Anti-Human CD340/ERBB2/HER2 Antibody (4D5V8) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4) | Login | Anti-Human CD340/ERBB2/HER2 Antibody (MAB 2C4) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD349/FZD9 Antibody (2933#) | Login | Anti-Human CD349/FZD9 Antibody (2933#) | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human CD37/TSPAN26 Antibody (HH1) | Login | Anti-Human CD37/TSPAN26 Antibody (HH1) | ||||||||||||||||
|
||||||||||||||||||


